Paper

Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.

Published Jun 1, 2007 · DOI · M. Oka, V. Karoor, N. Homma

Cardiovascular research

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTAnimal StudyHighly Cited

Study Snapshot

Dehydroepiandrosterone effectively inhibits hypoxic pulmonary hypertension by upregulating soluble guanylate cyclase protein expression and enhancing pulmonary artery vasodilator responsiveness to nitric oxide.

Population
Older adults (50-71 years)
Sample size
24
Methods
Observational
Outcomes
Body Mass Index projections
Results
Social networks mitigate obesity in older groups.

Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.

References

Citations